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PACAP-38 Signaling in Tetrahymena thermophila Involves NO and cGMP
John LUCAS, Mark RIDDLE, Janine BARTHOLOMEW, Brendan THOMAS, Jason FORNI,
L. Emery NICKERSON, Bradley Van HEUKELUM, Joshua PAULICK and Heather KURUVILLA
Cedarville University, Department of Science and Mathematics, Cedarville, OH, USA
Summary. Chemorepellents are signaling molecules, which have been shown to be important for mammalian neuronal development, and
are presumed to have a role in protozoan defense. Tetrahymena thermophila represent a good model system in which to study repellents
because of their ease of use in biochemical, behavioral, electrophysiological, and genetic analyses. In this study, we have used Tetrahymena
as a model in which to study the chemorepellent, PACAP. Using behavioral and biochemical (EIA) assays, we have found that the
NO/cGMP pathway plays an important role in PACAP signaling. An increase in intracellular calcium is also critical for PACAP avoidance,
which appears to be mediated through a pertussis toxin-sensitive G-protein.
Key words: chemorepellent, G-protein, nitric oxide, PACAP-38.
Abbreviations: cGMP - guanosine 3’5’ monophosphate, IMP - 2-imino-4-methylpiperidine, NO - nitric oxide, NOS - nitric oxide synthase,
PACAP - pituitary adenylate cyclase activating polypeptide.
INTRODUCTION
Chemorepellents are compounds that cause a cell to
exhibit avoidance. Some of these compounds have been
shown to be important in human neuronal development
(Zhu et al. 1999). Still, relatively little is known about
repellents and how they work. Ciliate model systems,
such as Tetrahymena thermophila, are a useful tool in
which to study repellents because they exhibit a distinc-
tive “avoidance behavior”, easily seen under a dissec-
tion microscope. They have been widely used in genet-
ics studies (Orias 1998), and can even be used in
electrophysiological experiments (Kuruvilla and
Hennessey 1998, 1999; Kim et al. 1999).
Tetrahymena respond to a number of compounds as
repellents, including ATP (Kim et al. 1999, Rosner et al.
2003), GTP (Kuruvilla et al. 1997, Iwamoto and Nakaoka
2002), and PACAP (Mace et al. 2000, Hassenzahl et al.
2001, Keedy et al. 2003), all of which appear to use
different receptors. Although avoidance behavior to
each of these compounds appears identical when ob-
served under a dissection microscope, the intracellular
pathways involved are not. Previous studies in our
laboratory have implicated a G-protein linked receptor in
PACAP signaling (Hassenzahl et al. 2001), which is
similar to signaling pathways utilized by vertebrate
PACAP receptors. ATP also appears to signal through a
G-protein linked receptor (Rosner et al. 2003); however,
Address for correspondence: Heather Kuruvilla, Cedarville
University, Department of Science and Mathematics, 251 North
Main St. Cedarville, OH 45314, USA
16  J. Lucas et al.
GTP signaling appears to involve a tyrosine kinase
pathway (Bartholomew et al., submitted).
PACAP has myriad actions in vertebrates. Although
originally isolated from brain, target cells include smooth
muscle cells along with a number of different neuronal
cell types (Forssmann and Said 1998). Vertebrate sec-
ond messenger pathways activated by PACAP include
protein kinases A and C, and pathways inhibited include
the JNK/SAPK pathway (Forssmann and Said 1998).
In parallel with mammalian systems, PACAP-38
avoidance in Tetrahymena has previously been shown
to involve an intricate pathway, which includes adenylyl
cyclase and phospholipase C (Hassenzahl et al. 2001).
Recent studies show that these pathways are also
involved in ATP avoidance, along with an NO pathway
(Rosner et al. 2003). In this study, we use pharmacologi-
cal and EIA assays as evidence that the NO/cGMP
pathway is also involved in PACAP-38 signaling in
Tetrahymena. The PACAP-38 response is also shown
to be calcium dependent and pertussis toxin sensitive.
Finally, a model of PACAP-38 signaling attempts to pull
together all of the pathways involved and postulates how
these may contribute to avoidance.
MATERIALS AND METHODS
Cell cultures. Tetrahymena thermophila B, strain SB2086, a
generous gift from T. M. Hennessey (SUNY at Buffalo) was used
throughout the study. Cells were incubated under sterile conditions at
25°C for 48 h after inoculation, without shaking, in the axenic medium
of Dentler (1988). No antibiotics were added to the media.
Chemicals and solutions. Behavioral bioassays were carried
out in a buffer containing 10 mM Trizma base, 0.5 mM MOPS,
50 µM CaCl2, pH 7.0. All repellents and inhibitors were dissolved in
this buffer. Compounds which were insoluble in aqueous solution
were first dissolved into a small quantity of DMSO, then immedi-
ately diluted into behavioral buffer at a dilution of 1:10,000 or higher.
PACAP-38 was obtained from the American Peptide Co. Sunny-
vale, CA. The G-protein inhibitor, pertussis toxin, was obtained from
Alexis Biochemicals, San Diego, CA. The calcium chelator, BAPTA-
AM, the guanylyl cyclase inhibitor, NS-2028, and the Quantizyme
Assay SystemÔ NO Kit were all obtained from BIOMOL Research
Laboratories, Plymouth Meeting, PA. The NOS inhibitors, 1400W
and 2-Imino-4-Methylpiperidine (IMP), the guanylyl cyclase inhibi-
tor, LY-83583, and the cGMP EIA kit, were obtained from Cayman
Chemical, Ann Arbor, MI. All other chemicals were obtained from
Sigma Chemical Company, St. Louis, MO.
Behavioral bioassays. In vivo behavioral bioassays were carried
out as previously described (Kuruvilla et al. 1997, Kim et al. 1999,
Mace et al. 2000). Cells were first washed in the assay buffer and
transferred to the first well of a 3-well spot microtiter plate. Cells
were then transferred to the second well of the microtiter plate, which
contained the inhibitor being tested, and were incubated for 10-
15 min, to allow time for cellular uptake of the inhibitor. If no
inhibitor was being tested, cells were simply incubated in fresh buffer
for 10-15 min. Individual cells were then transferred to the third well
of the microtiter plate, which contained a combination of the
chemorepellent (0.1 µM PACAP 38) and the test concentration
of inhibitor. If no inhibitors were being tested, cells were simply
transferred to the repellent. Each cell was then scored for avoidance
(+ or -) for each trial. Each trial consisted of ten cells. The mean ± SD
was calculated for at least three trials, and was expressed as “cells
showing avoidance, (%)”.
EIA assays. NO assays were carried out using two-day old cell
cultures. Cells were washed twice in buffer and diluted to a final
concentration of approximately 720 cells/ml. Cells were exposed to
 9 µM PACAP 38 for approximately 30 seconds, then spun down in
a benchtop microcentrifuge for 30 s. Supernatant was analyzed for
NO using a kit from BIOMOL, according to the manufacturer’s
instructions.
cGMP assays were carried out using two day old cell cultures.
Cells were concentrated to approximately 7.66 × 106 cells/ml. Cells
were exposed to 1 µM PACAP 38 for approximately 30 seconds,
then immediately lysed by freezing in liquid nitrogen and thawing.
Theophylline (1 µM) was added to the lysate to inhibit phosphodi-
esterases. Lysate was spun at 16,000 g for 30 min. Supernatant was
assayed for cGMP using a kit from Cayman Chemicals according to
the manufacturer’s instructions.
RESULTS
As seen previously (Mace et al. 2000, Hassenzahl
et al. 2001, Keedy et al. 2003), in vivo behavioral
bioassays indicate that PACAP-38 is an effective
chemorepellent in Tetrahymena (Fig. 1). The potency of
PACAP-38 was concentration dependent, and a maxi-
mum potency, causing 100% of cells to show avoidance,
was seen at 0.1 µM. This concentration was used in the
inhibitor studies which follow. The EC50 of this com-
pound was approximately 0.01 µM.
In order to determine whether NO was involved in
PACAP-38 avoidance, two NO inhibitors, 1400W and
IMP were used. Both inhibitors (Figs 2, 3) blocked
avoidance in a concentration-dependent manner. An
avoidance response near baseline (10-20%; Mace et
al. 2000) was achieved at 10 µM 1400W (23.3 ±  5.8%),
and 500 nM IMP (20 ±  5%). The EC50 for 1400W was
near 1 nM, and for IMP was near 0.1 nM. These data
implicate the NO pathway in PACAP signaling. In order
to confirm these results biochemically, EIA assays were
performed on intact cells. Using 9 µM PACAP, our
EIA assays showed a 148 ±  4.8% increase in NO levels
compared to control cells, confirming NO involvement in
the Tetrahymena response.
Since NO often activates guanylyl cyclase within
cells, and since the presence of a membrane-bound
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guanylyl cyclase in Tetrahymena has been documented
(Linder and Schultz 2002), we used two guanylyl cyclase
inhibitors, LY-83583, and NS-2028, in an attempt to
inhibit PACAP-38 avoidance. Both inhibitors (Figs 4, 5)
blocked avoidance in a concentration-dependent man-
ner. An avoidance response near baseline was achieved
using 20 µM LY-83583 (16.6 ±  5.8%), and 1 nM NS-
2028 (13.3 ±  5.8%). The EC50 for LY-83583 was near
0.1 nM, and for NS-2028 was near 0.05 nM. These data
implicate guanyl cyclase in PACAP-38 avoidance. In
Fig. 1. PACAP-38 is an effective chemorepellent in Tetrahymena.
In vivo behavioral bioassays (see Materials and Methods) were used
to show the concentration dependencies for avoidance reactions to
PACAP. The percentage of cells showing avoidance was determined
by observation of a single cell after transfer to the test solution. Each
trial consisted of ten cells, which were individually scored as to
whether or not avoidance occurred. Each point represents the mean ±
SD of three trials. Error bars, representing the standard deviation, are
shown for each point. Minimum concentration required to give 100%
avoidance was 0.1 µM for PACAP-38. This concentration was used
in the inhibition studies that follow. The EC50 of this compound was
approximately 0.01 µM.
Fig. 2. In vivo behavioral assays (see Materials and Methods) show
that the iNOS inhibitor, 1400W, reduced avoidance behavior to
0.1 µM PACAP to near baseline levels at a concentration of 10 µM
1400W. The IC50 of 1400W was approximately 1 nM.
Fig. 3. In vivo behavioral assays (see Materials and Methods) show
that the NOS inhibitor, IMP, reduced avoidance to 0.1 mM PACAP
to baseline levels at a concentration of 500 nM IMP. The IC50 of IMP
was approximately 1 nM.
Fig. 4. In vivo behavioral assays (see Materials and Methods) show
that the guanylyl cyclase inhibitor, LY-83583, reduced avoidance
behavior to 0.1 mM PACAP to near baseline levels at a concentration
of 20 mM LY-83583. The IC50 of LY-83583 was approximately
0.1 µM.
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order to confirm these results biochemically, we used
EIA assays performed on Tetrahymena lysate. Expo-
sure to 1 µM PACAP-38 increased cGMP levels to
351 ±  4.6% of control levels.
Since many NO synthases are calcium-dependent,
the membrane-bound guanylyl cyclase of Tetrahymena
has been shown to be calcium dependent (Linder and
Schultz 2002), and since Tetrahymena exhibit a calcium-
based depolarization when stimulated with lysozyme
(Kuruvilla and Hennessey 1998), which presumably acts
through the same receptor as PACAP (Mace et al.
2000, Keedy et al. 2003), we used the membrane-
permeable calcium chelator, BAPTA-AM, to see
whether avoidance would be blocked. As seen in Fig. 6,
exposure to 5 µM BAPTA-AM was sufficient to achieve
baseline avoidance. The EC50 of this compound was
0.5 µM.
Previous studies (Hassenzahl et al. 2001, Keedy et
al. 2003) indicate that the PACAP receptor is a
G-protein linked receptor. However, the pertussis toxin
sensitivity of this receptor has not previously been
tested. We found that pertussis toxin was an effective
inhibitor of PACAP avoidance, requiring a concentration
of just 0.01 µg/ml to achieve baseline avoidance (Fig. 7).
The EC50 of this compound was approximately
0.0001 µg/ml.
A proposed model of PACAP avoidance, based on
these and previous studies, is shown in Fig. 8. Arrows
broken with a question mark represent hypothetical
steps in the model, while unbroken arrows represent
confirmed steps in the pathway.
DISCUSSION
PACAP-38 is a convenient ligand to use for Tetrahy-
mena avoidance assays because low concentrations are
Fig. 5. In vivo behavioral assays (see Materials and Methods) show
that the guanylyl cyclase inhibitor, NS-2028, effectively eliminated
avoidance behavior to 0.1 mM PACAP at a concentration of 10 nM
NS-2028. The IC50 of NS-2028 was approximately 0.05 nM.
Fig. 6. In vivo behavioral assays (see Materials and Methods) show
that the membrane-permeable calcium chelator, BAPTA-AM, effec-
tively eliminated avoidance behavior to 0.1 mM PACAP at a concen-
tration of 10 mM BAPTA-AM. The IC50 of BAPTA-AM com-
pounds was 0.5 µM.
Fig. 7. In vivo behavioral assays (see Materials and Methods) show
that pertussis toxin, an inhibitor of Gi/o proteins, reduced avoidance
behavior to 0.1 mM PACAP to baseline levels at a concentration of
0.001 mg/ml pertussis toxin. The IC50 of pertussis toxin was near
0.00001 mg/ml.
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required in order to achieve avoidance (Fig. 1; Mace et
al. 2000, Hassenzahl et al. 2001, Keedy et al. 2003) and
because the ligand has been well studied in other sys-
tems. In Tetrahymena, however, the pharmacological
profile of the receptor is different from known PACAP
receptors in other systems. For example, the antagonists,
PACAP 6-27 and 6-38, which competitively inhibit many
PACAP receptors actually serve as agonists for Tet-
rahymena PACAP receptors (Keedy et al. 2003).
Previous studies (Hassenzahl et al. 2001) have shown
that the PACAP-38 pathway in Tetrahymena is linked
to a G-protein pathway which involves adenylyl cyclase
and phospholipase C, presumably resulting in the forma-
tion of cAMP as well as the release of calcium from
internal stores. Earlier studies (Kuruvilla and Hennessey
1998) link the lysozyme response, which presumably
occurs through the same receptor as PACAP-38 (Mace
et al. 2000) to a calcium-linked depolarization. However,
the mechanism of avoidance has not yet been estab-
lished. In this study, we present evidence that NO and
cGMP are also critical for PACAP avoidance (Figs. 2-
5). Intracellular calcium (Fig. 6) is also essential in order
for avoidance to occur. A pertussis toxin-sensitive
G protein is presumably involved (Fig. 7). How do all
these data, together with that from other laboratories,
come together to form a coherent model of PACAP
avoidance? Questions remain, yet when the available
data are compiled, a complex picture begins to emerge.
One of the first points made clear by the data is that
calcium is critical for avoidance. When the membrane-
permeable calcium chelator, BAPTA-AM, is introduced
into the cells, avoidance ceases (Fig. 6). Interestingly,
we have seen this same behavior with the repellents ATP
and GTP (Rosner et al. 2003; Bartholomew et al.,
submitted). This is consistent with past electrophysi-
ological data (Kuruvilla and Hennessey 1998, Kim et al.
1999) showing that lysozyme, GTP, and ATP all exhibit
calcium-based depolarizations. In addition, PACAP
(Hassenzahl et al. 2001) and ATP (Rosner et al. 2003)
also utilize the phospholipase C pathway, presumably
releasing calcium from internal stores.
The roles for calcium in avoidance are also beginning
to emerge. For example, many nitric oxide synthase
isoforms are calcium dependent. Our pharmacological
data with 1400W (Fig. 2) and IMP (Fig. 3) suggest a role
for NO in PACAP avoidance, and our EIA detection
assay confirms this result. We have seen similar results
with ATP (Rosner et al. 2003) and GTP (Bartholomew
et al., submitted, personal comn.). Interestingly, 1400W
is selective for iNOS isoforms, which are calcium inde-
pendent, and the low concentrations of IMP needed for
inhibition are also characteristic of an iNOS. NO has
previously been implicated in Tetrahymena survival
(Christensen et al. 1996); however, the type of NOS
involved is unknown. It is possible that the NOS of
Tetrahymena is calcium-dependent. Our data seem to
support this, since the rise in NO is instantaneous,
correlating with the calcium depolarization and presum-
ably the phospholipase C pathway as well. However,
inducible nitric oxide synthases are turned on at the
transcriptional level, requiring hours to take effect (for
example, see Arimoto and Bing 2003). Future experi-
ments are required to determine whether the NOS of
Tetrahymena is calcium-dependent.
Another possible role of calcium in avoidance is the
triggering of guanylyl cyclase. In Tetrahymena, a mem-
brane bound isoform of this enzyme has been shown to
be calcium-dependent (Linder and Schultz 2002). Our
pharmacological studies indicate that guanylyl cyclase is
involved in PACAP-38 avoidance, as the guanylyl cy-
clase inhibitors, LY-83583 and NS-2028, block avoidance
to PACAP-38 (Figs 4, 5). Both of these inhibitors have
been previously shown to block soluble forms of guanylyl
cyclase. If the guanylyl cyclase activated by PACAP-38
is indeed a soluble isoform, its calcium dependence is
unknown. If, however, the drugs were blocking the
membrane-bound cyclase mentioned previously, then
calcium would have a role in cGMP formation.
As detected by EIA, cGMP is also produced at higher
levels in cells, which have been exposed to PACAP-38.
We have seen similar EIA and pharmacological results
for ATP and GTP (Rosner et al. 2003; Bartholomew
et al., submitted), suggesting that the cGMP pathway,
like intracellular calcium, may be critical for ciliary
reversal.
Another potential role of calcium in avoidance has
emerged from recent data. Hennessey et al. (2003),
have shown that calcium-dependent ciliary reversal in
Tetrahymena depends on properly functioning inner arm
dynein 1 (I1). Their hypothesis is that a “calcium sensor”
protein binds to and activates I1. The calcium sensor
protein may be regulated by the NO/cGMP pathway or
another of the pathways involved in avoidance.
The G-protein involved in avoidance is also interesting
to consider. Our data suggest that the G-protein is
pertussis toxin-sensitive (Fig. 7), a characteristic of
Gi/o proteins. This same pattern is seen in the ATP
chemoresponse of Tetrahymena (Rosner et al. 2003).
In many mammalian cells, PACAP acts through a
Gs protein; however, in smooth muscle, PACAP acti-
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vates a calcium-dependent, membrane-bound NO syn-
thase via a Gi1-2 protein (Murthy and Makhlouf 1996).
Perhaps something similar is occurring during PACAP
avoidance in Tetrahymena.
The diagram shown in Fig. 8 represents the pathways
involved in PACAP-38 avoidance. As seen in the figure,
the pathway is rather complex, and many questions still
remain unanswered. This model represents a work of
continuing research and will continue to develop as more
is discovered regarding this specific signaling pathway
and ciliary function in general.
Further studies will be necessary to fully understand
Tetrahymena avoidance behavior. The data we have
obtained highlight the elegance and complexity of this
model system for behavioral studies. Its adaptability for
genetic experiments will make it an excellent candidate
for future studies that may help us to understand protists
better, as well as to gain a more complete knowledge of
chemorepellent signaling in higher organisms.
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